サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：持続的腎代替療法の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2023～2030年の予測
市場調査レポート
商品コード
1392404

持続的腎代替療法の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2023～2030年の予測

Global Continuous Renal Replacement Therapy Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日: | 発行: Value Market Research | ページ情報: 英文 240 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
持続的腎代替療法の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2023～2030年の予測
出版日: 2023年11月01日
発行: Value Market Research
ページ情報: 英文 240 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

持続的腎代替療法市場の世界需要は、2023～2030年の調査期間においてCAGR 10.62%で、2022年の44億1,000万米ドルから2030年にはほぼ109億4,000万米ドルの市場規模に達すると推定されます。

持続的腎代替療法は、腎支持を必要とする急性腎障害の重症患者、特に血行動態が不安定な患者に対して、腎支持を行うための治療オプションとしてよく知られています。持続的腎代替療法の主な利点は、単位時間当たりの体液または溶質の除去速度が遅いことです。持続的腎代替療法は体液中の毒素をろ過することができます。一方、持続的腎代替療法は最大24時間持続可能です。

市場力学：

糖尿病、高血圧、心血管疾患、炎症性腎臓病の主要な危険因子である慢性腎臓病の有病率の増加は、今後数年間、持続的腎代替療法の需要を促進すると予想されます。さらに、世界の高齢者人口の急増に伴い、腎臓関連疾患の有病率は大幅に増加し、予測期間中に持続的腎代替療法市場の成長を促進すると予想されます。さらに、確立された医療インフラと持続的腎代替療法における新技術の高い採用率が、市場成長を後押ししています。さらに、パンデミック時にメーカーや政府が持続的腎代替療法に関する認知度を高めるために行ったイニシアティブの多さが、持続的腎代替療法市場の成長を後押しすると予想されます。しかし、持続的腎代替療法に関連する高コストは、腎代替療法市場の成長を阻害すると思われます。

本レポートでは、ポーターのファイブフォースモデル、市場魅力度分析、バリューチェーン分析を取り上げています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールは、持続的腎代替療法の世界市場における各セグメントを包括的に評価することもできます。持続的腎代替療法産業の成長と動向は、この調査に全体的なアプローチを提供します。

地域分析：

本セクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東アフリカにおける持続的腎代替療法市場の現在と将来の需要を強調した地域展望をカバーします。さらに、このレポートでは、すべての主要地域における個々の用途セグメントの需要、推定・予測に焦点を当てています。

カスタム要件がある場合は、お問い合わせください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 持続的腎代替療法：産業分析

  • イントロダクション：市場力学
  • 市場の促進要因
  • 市場抑制要因
  • 機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場魅力度分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーのリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

第5章 COVID-19発生の影響分析

第6章 持続的腎代替療法の世界市場分析：製品別

  • 製品別概要
  • 実績データと予測データ
  • 製品別分析
  • 透析液と交換液
  • ディスポーザブル
  • 血液フィルター
  • 血液ラインセット＆チューブ
  • その他のディスポーザブル
  • 持続的腎代替療法システム

第7章 持続的腎代替療法の世界市場分析：モダリティ別

  • モダリティ別概要
  • 実績データと予測データ
  • モダリティ別分析
  • 持続的静脈血液濾過（CVVH）
  • 持続的静脈血液濾過透析（CVVHDF）
  • 持続的静脈血液透析（CVVHD）
  • 緩徐式持続限外濾過（SCUF）

第8章 持続的腎代替療法の世界市場分析：年齢層別

  • 年齢層別概要
  • 実績データと予測データ
  • 年齢層別分析
  • 成人
  • 小児・新生児

第9章 持続的腎代替療法の世界市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州：セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他の欧州
  • アジア太平洋売上分析
    • 概要、実績と予測
    • アジア太平洋：セグメント別
    • アジア太平洋：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • その他のアジア太平洋
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他のラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他の中東とアフリカ

第10章 持続的腎代替療法企業の競合情勢

  • 持続的腎代替療法市場の競合
  • 提携・協力・契約
  • 合併・買収
  • 新製品の発売
  • その他の開発

第11章 企業プロファイル

  • 企業シェア分析
  • 市場集中度
  • Baxter International Inc.（米国）
  • Fresenius Medical Care AG & Co. KGaA（ドイツ）
  • NIKKISO CO. LTD.（日本）
  • B. Braun Melsungen AG（ドイツ）
  • Asahi Kasei Corporation（日本）
  • Toray Medical Co. Ltd.（日本）
  • Infomed SA（スイス）
  • Medtronic plc（アイルランド）
  • Medica S.p.A.（イタリア）
  • Medical Components Inc.（米国）
  • Medites Pharma spol. s.r.o.（チェコ共和国）
  • SWS Hemodialysis Care Co. Ltd.（中国）
  • Ningbo Tianyi Medical Devices Co. Ltd.（中国）
  • Nipro Corporation（日本）
  • Anjue Medical Equipment Co. Ltd.（中国）
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Product (Units and USD MN)
  • Dialysates And Replacement Fluids Market Sales by Geography (Units and USD MN)
  • Disposables Market Sales by Geography (Units and USD MN)
  • Hemofilters Market Sales by Geography (Units and USD MN)
  • Bloodline Sets & Tubes Market Sales by Geography (Units and USD MN)
  • Other Disposables Market Sales by Geography (Units and USD MN)
  • CRRT Systems Market Sales by Geography (Units and USD MN)
  • Analysis Market by Modality (Units and USD MN)
  • Continuous Venovenous Hemofiltration (CVVH) Market Sales by Geography (Units and USD MN)
  • Continuous Venovenous Hemodiafiltration (CVVHDF) Market Sales by Geography (Units and USD MN)
  • Continuous Venovenous Haemodialysis (CVVHD) Market Sales by Geography (Units and USD MN)
  • Slow Continuous Ultrafiltration (SCUF) Market Sales by Geography (Units and USD MN)
  • Analysis by Age group (Units and USD MN)
  • Adults Market Sales by Geography (Units and USD MN)
  • Pediatrics /Neonates Market Sales by Geography (Units and USD MN)
  • Global Continuous Renal Replacement Therapy Market Sales by Geography (Units and USD MN)
  • North America Market Analysis (Units and USD MN)
  • United State Market Analysis (Units and USD MN)
  • Canada Market Analysis (Units and USD MN)
  • Mexico Market Analysis (Units and USD MN)
  • Europe Market Analysis (Units and USD MN)
  • Europe Market Estimate by Country (Units and USD MN)
  • United Kingdom Market Analysis (Units and USD MN)
  • France Market Analysis (Units and USD MN)
  • Germany Market Analysis (Units and USD MN)
  • Italy Market Analysis (Units and USD MN)
  • Russia Market Analysis (Units and USD MN)
  • Spain Market Analysis (Units and USD MN)
  • Rest of Europe Market Analysis (Units and USD MN)
  • Asia Pacific Market Analysis (Units and USD MN)
  • China Market Analysis (Units and USD MN)
  • Japan Market Analysis (Units and USD MN)
  • India Market Analysis (Units and USD MN)
  • South Korea Market Analysis (Units and USD MN)
  • Australia Market Analysis (Units and USD MN)
  • Rest of Asia Pacific Market Analysis (Units and USD MN)
  • Latin America Market Analysis (Units and USD MN)
  • Brazil Market Analysis (Units and USD MN)
  • Argentina Market Analysis (Units and USD MN)
  • Peru Market Analysis (Units and USD MN)
  • Chile Market Analysis (Units and USD MN)
  • Rest of Latin America Market Analysis (Units and USD MN)
  • Middle East & Africa Market Analysis (Units and USD MN)
  • Saudi Arabia Market Analysis (Units and USD MN)
  • UAE Market Analysis (Units and USD MN)
  • Israel Market Analysis (Units and USD MN)
  • South Africa Market Analysis (Units and USD MN)
  • Rest of Middle East and Africa Market Analysis (Units and USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Continuous Renal Replacement Therapy Report
  • Market Research Process
  • Market Research Methodology
  • Global Continuous Renal Replacement Therapy Market Size, by Region (Units and USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Product
  • Market Attractiveness Analysis by Modality
  • Market Attractiveness Analysis by Age group
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Product (Units and USD MN)
  • Dialysates And Replacement Fluids Market Sales by Geography (Units and USD MN)
  • Disposables Market Sales by Geography (Units and USD MN)
  • Hemofilters Market Sales by Geography (Units and USD MN)
  • Bloodline Sets & Tubes Market Sales by Geography (Units and USD MN)
  • Other Disposables Market Sales by Geography (Units and USD MN)
  • CRRT Systems Market Sales by Geography (Units and USD MN)
  • Global Market Analysis by Modality (Units and USD MN)
  • Continuous Venovenous Hemofiltration (CVVH) Market Sales by Geography (Units and USD MN)
  • Continuous Venovenous Hemodiafiltration (CVVHDF) Market Sales by Geography (Units and USD MN)
  • Continuous Venovenous Haemodialysis (CVVHD) Market Sales by Geography (Units and USD MN)
  • Slow Continuous Ultrafiltration (SCUF) Market Sales by Geography (Units and USD MN)
  • Global Market Analysis by Age group (Units and USD MN)
  • Adults Market Sales by Geography (Units and USD MN)
  • Pediatrics /Neonates Market Sales by Geography (Units and USD MN)
  • Global Market Sales (Units and USD MN)
  • North America Market Sales (Units and USD MN)
  • Europe Market Sales (Units and USD MN)
  • Asia Pacific Market Sales (Units and USD MN)
  • Latin America Market Sales (Units and USD MN)
  • Middle East & Africa Market Sales (Units and USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR11218337

The global demand for Continuous Renal Replacement Therapy Market is presumed to reach the market size of nearly USD 10.94 BN by 2030 from USD 4.41 BN in 2022 with a CAGR of 10.62% under the study period of 2023 - 2030.

Continuous renal replacement therapy (CRRT) is a well-known treatment option for critically ill patients with acute kidney injury who require renal support, particularly hemodynamically unstable patients, to provide renal support. The main benefit of continuous renal replacement therapy is that it removes fluid or solute at a slower rate per unit time. CRRT technique could filter the toxins from fluids. CRRT, on the other hand, can last up to 24 hours.

MARKET DYNAMICS:

The increased prevalence of chronic kidney disease, a major risk factor for diabetes, hypertension, cardiovascular disease, and inflammatory kidney disease, is expected to drive the demand for continuous renal replacement therapy in the upcoming years. Moreover, with the rapid growth in the geriatric population globally, the prevalence of kidney-related diseases is expected to increase significantly and propel the continuous renal replacement therapy (CRRT) market growth during the forecast period. Furthermore, well-established healthcare infrastructure and high adoption rates of new technologies in continuous renal replacement therapy propel the market growth. In addition, the high number of initiatives taken by the manufacturers and government during the pandemic to increase awareness regarding CRRT is expected to boost the growth of the market for continuous renal replacement therapy. However, the high cost associated with continuous renal replacement therapy procedures will impede the growth of the renal replacement therapy market.

The report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of continuous renal replacement therapy. The growth and trends of Continuous Renal Replacement Therapy Industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the continuous renal replacement therapy market report provides detailed data on the segments by analyzing them at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

  • Dialysates And Replacement Fluids
  • Disposables
  • Hemofilters
  • Bloodline Sets & Tubes
  • Other Disposables
  • Crrt Systems

By Modality

  • Continuous Venovenous Hemofiltration (CVVH)
  • Continuous Venovenous Hemodiafiltration (CVVHDF)
  • Continuous Venovenous Haemodialysis (CVVHD)
  • Slow Continuous Ultrafiltration (SCUF)

By Age Group

  • Adults
  • Pediatrics /Neonates

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Continuous Renal Replacement Therapy market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the continuous renal replacement therapy market include Baxter International Inc. (US), Fresenius Medical Care AG & Co. KGaA (Germany), NIKKISO CO., LTD. (Japan), B. Braun Melsungen AG (Germany), Asahi Kasei Corporation (Japan), Toray Medical Co., Ltd. (Japan), Infomed SA (Switzerland), Medtronic plc (Ireland), Medica S.p.A. (Italy), Medical Components, Inc. (US), Medites Pharma spol. S.r.o. (Czech Republic), SWS Hemodialysis Care Co., Ltd. (China), Ningbo Tianyi Medical Devices Co., Ltd. (China), Nipro Corporation (Japan), and Anjue Medical Equipment Co., Ltd. (China), among others. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . CONTINUOUS RENAL REPLACEMENT THERAPY - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By Modality
    • 3.7.3 Market Attractiveness Analysis By Age group
    • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET ANALYSIS BY PRODUCT

  • 6.1 Overview by Product
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Product
  • 6.4 Dialysates And Replacement Fluids Historic and Forecast Sales by Regions
  • 6.5 Disposables Historic and Forecast Sales by Regions
  • 6.6 Hemofilters Historic and Forecast Sales by Regions
  • 6.7 Bloodline Sets & Tubes Historic and Forecast Sales by Regions
  • 6.8 Other Disposables Historic and Forecast Sales by Regions
  • 6.9 CRRT Systems Historic and Forecast Sales by Regions

7 . GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET ANALYSIS BY MODALITY

  • 7.1 Overview by Modality
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Modality
  • 7.4 Continuous Venovenous Hemofiltration (CVVH) Historic and Forecast Sales by Regions
  • 7.5 Continuous Venovenous Hemodiafiltration (CVVHDF) Historic and Forecast Sales by Regions
  • 7.6 Continuous Venovenous Haemodialysis (CVVHD) Historic and Forecast Sales by Regions
  • 7.7 Slow Continuous Ultrafiltration (SCUF) Historic and Forecast Sales by Regions

8 . GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET ANALYSIS BY AGE GROUP

  • 8.1 Overview by Age group
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by Age group
  • 8.4 Adults Historic and Forecast Sales by Regions
  • 8.5 Pediatrics /Neonates Historic and Forecast Sales by Regions

9 . GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2. North America By Segment Sales Analysis
    • 9.3.3. North America By Country Sales Analysis
    • 9.3.4. United State Sales Analysis
    • 9.3.5. Canada Sales Analysis
    • 9.3.6. Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2. Europe by Segment Sales Analysis
    • 9.4.3. Europe by Country Sales Analysis
    • 9.4.4. United Kingdom Sales Analysis
    • 9.4.5. France Sales Analysis
    • 9.4.6. Germany Sales Analysis
    • 9.4.7. Italy Sales Analysis
    • 9.4.8. Russia Sales Analysis
    • 9.4.9. Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2. Asia Pacific by Segment Sales Analysis
    • 9.5.3. Asia Pacific by Country Sales Analysis
    • 9.5.4. China Sales Analysis
    • 9.5.5. India Sales Analysis
    • 9.5.6. Japan Sales Analysis
    • 9.5.7. South Korea Sales Analysis
    • 9.5.8. Australia Sales Analysis
    • 9.5.9. Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2. Latin America by Segment Sales Analysis
    • 9.6.3. Latin America by Country Sales Analysis
    • 9.6.4. Brazil Sales Analysis
    • 9.6.5. Argentina Sales Analysis
    • 9.6.6. Peru Sales Analysis
    • 9.6.7. Chile Sales Analysis
    • 9.6.8. Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2. Middle East & Africa by Segment Sales Analysis
    • 9.7.3. Middle East & Africa by Country Sales Analysis
    • 9.7.4. Saudi Arabia Sales Analysis
    • 9.7.5. UAE Sales Analysis
    • 9.7.6. Israel Sales Analysis
    • 9.7.7. South Africa Sales Analysis
    • 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE CONTINUOUS RENAL REPLACEMENT THERAPY COMPANIES

  • 10.1. Continuous Renal Replacement Therapy Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11 . COMPANY PROFILES OF CONTINUOUS RENAL REPLACEMENT THERAPY INDUSTRY

  • 11.1. Company Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Baxter International Inc. (US)
    • 11.3.1. Company Overview
    • 11.3.2. Company Revenue
    • 11.3.3. Products
    • 11.3.4. Recent Developments
  • 11.4. Fresenius Medical Care AG & Co. KGaA (Germany)
    • 11.4.1. Company Overview
    • 11.4.2. Company Revenue
    • 11.4.3. Products
    • 11.4.4. Recent Developments
  • 11.5. NIKKISO CO. LTD. (Japan)
    • 11.5.1. Company Overview
    • 11.5.2. Company Revenue
    • 11.5.3. Products
    • 11.5.4. Recent Developments
  • 11.6. B. Braun Melsungen AG (Germany)
    • 11.6.1. Company Overview
    • 11.6.2. Company Revenue
    • 11.6.3. Products
    • 11.6.4. Recent Developments
  • 11.7. Asahi Kasei Corporation (Japan)
    • 11.7.1. Company Overview
    • 11.7.2. Company Revenue
    • 11.7.3. Products
    • 11.7.4. Recent Developments
  • 11.8. Toray Medical Co. Ltd. (Japan)
    • 11.8.1. Company Overview
    • 11.8.2. Company Revenue
    • 11.8.3. Products
    • 11.8.4. Recent Developments
  • 11.9. Infomed SA (Switzerland)
    • 11.9.1. Company Overview
    • 11.9.2. Company Revenue
    • 11.9.3. Products
    • 11.9.4. Recent Developments
  • 11.10. Medtronic plc (Ireland)
    • 11.10.1. Company Overview
    • 11.10.2. Company Revenue
    • 11.10.3. Products
    • 11.10.4. Recent Developments
  • 11.11. Medica S.p.A. (Italy)
    • 11.11.1. Company Overview
    • 11.11.2. Company Revenue
    • 11.11.3. Products
    • 11.11.4. Recent Developments
  • 11.12. Medical Components Inc. (US)
    • 11.12.1. Company Overview
    • 11.12.2. Company Revenue
    • 11.12.3. Products
    • 11.12.4. Recent Developments
  • 11.13. Medites Pharma spol. s.r.o. (Czech Republic)
    • 11.13.1. Company Overview
    • 11.13.2. Company Revenue
    • 11.13.3. Products
    • 11.13.4. Recent Developments
  • 11.14. SWS Hemodialysis Care Co. Ltd. (China)
    • 11.14.1. Company Overview
    • 11.14.2. Company Revenue
    • 11.14.3. Products
    • 11.14.4. Recent Developments
  • 11.15. Ningbo Tianyi Medical Devices Co. Ltd. (China)
    • 11.15.1. Company Overview
    • 11.15.2. Company Revenue
    • 11.15.3. Products
    • 11.15.4. Recent Developments
  • 11.16. Nipro Corporation (Japan)
    • 11.16.1. Company Overview
    • 11.16.2. Company Revenue
    • 11.16.3. Products
    • 11.16.4. Recent Developments
  • 11.17. Anjue Medical Equipment Co. Ltd. (China)
    • 11.17.1. Company Overview
    • 11.17.2. Company Revenue
    • 11.17.3. Products
    • 11.17.4. Recent Developments
  • 11.18. Others
    • 11.18.1. Company Overview
    • 11.18.2. Company Revenue
    • 11.18.3. Products
    • 11.18.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies